Skip to content

13F-HR filed by NOVO HOLDINGS A/S

NOVO HOLDINGS A/S filed this 13F-HR for the quarter ended 2020-09-30, filed 2020-11-16, with 42 holding rows worth $2,014,482,000.

Accession
0000950123-20-011935
Filed
2020-11-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2020

A holdings report, 42 entries on the cover page, a total value of $2,014,482,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,014,483,000 with VALUE read as thousands by filing date, 13F file number 028-16231. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
VTI922908769COM3,070,400$522,920,000thousands by filing date
Apple Inc037833100COM1,252,104$145,006,000thousands by filing date
CATALENT INC USD 0.01148806102COM1,626,000$139,283,000thousands by filing date
HARMONY BIOSCIENCES HLDGS IN413197104COM3,754,973$127,294,000thousands by filing date
CABLE ONE INC12685J105COM57,291$108,018,000thousands by filing date
INOGEN INC45780L104COM3,549,320$102,930,000thousands by filing date
Medtronic PlcG5960L103COM988,136$102,687,000thousands by filing date
BROOKFIELD ASSET MANAGEMENT IN112585104CL A LTD VT SH3,070,957$101,526,000thousands by filing date
NKARTA INC65487U108COMMON STOCK2,793,864$83,984,000thousands by filing date
MORPHIC HLDG INC61775R105COM2,645,446$72,326,000thousands by filing date
INOZYME PHARMA INC45790W108COM2,569,379$67,549,000thousands by filing date
MIRUM PHARMACEUTICALS INC604749101COM2,445,147$47,118,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM2,320,026$32,759,000thousands by filing date
VAXCYTE INC COM92243G108Stock651,255$32,159,000thousands by filing date
GALERA THERAPEUTICS EQUICLASS EQUITY36338D108COMMON STOCK3,409,021$30,818,000thousands by filing date
CHECKMATE PHARMACEUTICALS IN162818108COM2,170,100$24,978,000thousands by filing date
SEASPINE HLDGS CORP81255T108COM1,677,492$23,988,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM234,979$21,783,000thousands by filing date
SI BONE INC825704109COM698,504$16,569,000thousands by filing date
PROTAGONIST THERAPEUTICS74366E102COM794,369$15,530,000thousands by filing date
Milestone Pharmaceuticals Inc59935V107COM2,080,585$15,230,000thousands by filing date
FLEXION THERAPEUTICS INC33938J106COM1,403,370$14,609,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock430,107$13,824,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM384,938$12,672,000thousands by filing date
CONSTELLATION PHARMACEUTICALS INC.210373106Common Stock578,134$11,713,000thousands by filing date
VERONA PHARMA PLC925050106SPONSORED ADS1,800,747$11,237,000thousands by filing date
AKOUOS INC00973J101COM458,606$10,488,000thousands by filing date
SPERO THERAPEUTICS INC84833T103COM931,099$10,391,000thousands by filing date
FREELINE THERAPEUTICS HLDGS35655L107SPONSORED ADS665,000$10,381,000thousands by filing date
AERIE PHARMACEUTICALS INC00771V108COM807,656$9,506,000thousands by filing date
CUREVAC N VN2451R105COM201,642$9,386,000thousands by filing date
SILK ROAD MEDICAL INC82710M100COMMON STOCK125,428$8,430,000thousands by filing date
INTERSECT ENT INC46071F103COM513,515$8,375,000thousands by filing date
INSPIRE MED SYS INC COM457730109Stock59,645$7,697,000thousands by filing date
ACUTUS MED INC005111109COM255,000$7,599,000thousands by filing date
ZOGENIX INC.98978L204Common Stock325,814$5,842,000thousands by filing date
CORVUS PHARMACEUTICALS INC221015100COM1,389,498$5,572,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM84,600$5,500,000thousands by filing date
INARI MED INC45332Y109COM75,500$5,211,000thousands by filing date
AKEBIA THERAPEUTICS INC00972D105COMMON STOCK1,987,506$4,989,000thousands by filing date
CRINETICS PHARMACEUTICALS INC COM22663K107Stock271,378$4,252,000thousands by filing date
ENTASIS THERAPEUTICS HLDGS I293614103COM1,153,911$2,354,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-20-011935this filing2020-11-16acceptance time not in the bulk data set